Literature DB >> 15566353

The role of granulocyte transfusions in neutropenic patients.

M Bishton1, R Chopra.   

Abstract

The precise role for donor granulocyte infusions remains to be delineated, partly because of the lack of defined clinical trials. The aim of this article is to summarize the studies undertaken so far and highlight the logistical problems associated with undertaking future studies. We also aim to provide a practical guide to the application of this therapeutic approach.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15566353     DOI： 10.1111/j.1365-2141.2004.05221.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


  9 in total

1.  Feasibility of salvage cord blood transplantation following fludarabine, melphalan and low-dose TBI for graft rejection after hematopoietic stem cell transplantation.

Authors:  K Ishiyama; J Takeda; T Kondo; N Sugimoto; H Kawabata; T Kitano; A Takaori-Kondo
Journal:  Bone Marrow Transplant       Date:  2016-02-15       Impact factor: 5.483

2.  Guidelines for safety management of granulocyte transfusion in Japan.

Authors:  Akimichi Ohsaka; Atsushi Kikuta; Hitoshi Ohto; Akira Ohara; Akaru Ishida; Koji Osada; Tetsunori Tasaki; Akira Kamitamari; Asayuki Iwai; Shunro Kai; Taira Maekawa; Yasutaka Hoshi
Journal:  Int J Hematol       Date:  2010-02-11       Impact factor: 2.490

3.  Human polymorphonuclear neutrophils specifically recognize and kill cancerous cells.

Authors:  Jun Yan; Goetz Kloecker; Chris Fleming; Michael Bousamra; Richard Hansen; Xiaoling Hu; Chuanlin Ding; Yihua Cai; Dong Xiang; Howard Donninger; John W Eaton; Geoffrey J Clark
Journal:  Oncoimmunology       Date:  2014-07-03       Impact factor: 8.110

4.  Experimental evidence that granulocyte transfusions are efficacious in treatment of neutropenic hosts with pulmonary aspergillosis.

Authors:  Marife Martinez; Vicky Chen; Ann-Jay Tong; Kelsey Hamilton; Karl V Clemons; David A Stevens
Journal:  Antimicrob Agents Chemother       Date:  2013-02-04       Impact factor: 5.191

5.  Human AdV-specific T cells: persisting in vitro functionality despite lethal irradiation.

Authors:  R Geyeregger; C Freimüller; J Stemberger; G Fischer; V Witt; G Fritsch
Journal:  Bone Marrow Transplant       Date:  2014-04-28       Impact factor: 5.483

6.  Hematopoietic stem cell transplantation in a very high risk group of patients with the support of granulocyte transfusion.

Authors:  Idil Yenicesu; Gülsan Sucak; Günter Dilsiz; Sahika Zeynep Akı; Zeynep Arzu Yeğin
Journal:  Indian J Hematol Blood Transfus       Date:  2011-06-05       Impact factor: 0.900

7.  Risk stratification by 30-day prognostic factors of clinical outcomes after granulocyte transfusion in acute myeloid leukemia: A single-center retrospective study.

Authors:  Jaeeun Yoo; Hyung Suk Cho; Jae-Ho Yoon; Byung Sik Cho; Hee-Je Kim; Dong-Gun Lee; Dong Wook Jekarl; Myungshin Kim; Eun-Jee Oh; Yeon-Joon Park; Yonggoo Kim
Journal:  PLoS One       Date:  2022-08-30       Impact factor: 3.752

8.  Nanoparticle clearance is governed by Th1/Th2 immunity and strain background.

Authors:  Stephen W Jones; Reid A Roberts; Gregory R Robbins; Jillian L Perry; Marc P Kai; Kai Chen; Tao Bo; Mary E Napier; Jenny P Y Ting; Joseph M Desimone; James E Bear
Journal:  J Clin Invest       Date:  2013-06-17       Impact factor: 14.808

Review 9.  Infections Caused by Acinetobacter baumannii in Recipients of Hematopoietic Stem Cell Transplantation.

Authors:  Khalid Ahmed Al-Anazi; Asma M Al-Jasser
Journal:  Front Oncol       Date:  2014-07-14       Impact factor: 6.244
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.